Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission
- PMID: 220843
Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission
Abstract
Experiments on male albino mice were carried out in order to determine the effects of drugs connecting with the GABA-ergic, dopaminergic and cholinergic transmission, on apomorphine stereotypies. The agents acting on GABA-ergic transmission are found to reduce the intensity of apomorphine stereotypies in the following order (arranged from strongest to weakest effect and expressed in doses of microgram per mouse: GABA (100), aminooxyacetic acid (5), diazepam (20), picrotoxin (1), GABA (10), semicarbazide (30), picrotoxin (0.1). The agents acting on the dopaminergic transmission also reduce apomorphine stereotypies in the following order: haloperidol (20;2), L-DOPA (500 mg/kg, i. p.), alpha-methylparatyrosine (150 mg/kg, i. p.) diethyldithiocarbamate (200). The strongest antagonistic effect in the two groups of agents studied was found for haloperidol. The agents acting on the cholinergic transmission (agonists and antagonists of muscarinic and nicotinic cholinoreceptors) have no significant effect on apomorphine stereotypies. It is assumed that the striatum is not the only brain structure responsible for apomorphine stereotypies.
Similar articles
-
Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission.Acta Physiol Pharmacol Bulg. 1978;4(3):65-70. Acta Physiol Pharmacol Bulg. 1978. PMID: 220844
-
Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.Acta Physiol Pharmacol Bulg. 1982;8(3):67-73. Acta Physiol Pharmacol Bulg. 1982. PMID: 6820612
-
Role of dopaminergic and GABA-ergic interactions in seizure susceptibility.Arch Int Pharmacodyn Ther. 1979 Oct;241(2):280-6. Arch Int Pharmacodyn Ther. 1979. PMID: 526081
-
[Modulation of dopaminergic receptor sensitivity in the central nervous system: important parameters in synaptic function regulation].Encephale. 1979;5(2):121-49. Encephale. 1979. PMID: 38958 Review. French.
-
Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.Pol J Pharmacol Pharm. 1976;28(5):469-93. Pol J Pharmacol Pharm. 1976. PMID: 796834 Review. No abstract available.
Cited by
-
Pharmacologic Evaluation of Antidepressant Activity and Synthesis of 2-Morpholino-5-phenyl-6H-1,3,4-thiadiazine Hydrobromide.Pharmaceuticals (Basel). 2016 May 19;9(2):27. doi: 10.3390/ph9020027. Pharmaceuticals (Basel). 2016. PMID: 27213404 Free PMC article.